| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-11 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0007 |